Literature DB >> 6192512

Verapamil inhibits mediator release from human lung in vitro.

V Y Lee, J M Hughes, J P Seale, D M Temple.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6192512      PMCID： PMC459564          DOI： 10.1136/thx.38.5.386

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  10 in total

1.  Effects of local anaesthetics on prostaglandin biosynthesis in vitro.

Authors:  H Kunze; E Bohn; W Vogt
Journal:  Biochim Biophys Acta       Date:  1974-09-19

Review 2.  The role of slow-reacting substance in asthma.

Authors:  W E Brocklehurst
Journal:  Adv Drug Res       Date:  1970

3.  Effect of lipoxygenase inhibitors on release of slow-reacting substances from human lung.

Authors:  C L Armour; J M Hughes; J P Seale; D M Temple
Journal:  Eur J Pharmacol       Date:  1981-06-10       Impact factor: 4.432

4.  Inhibition of exercise-induced asthma by a calcium antagonist, nifedipine.

Authors:  J Cerrina; A Denjean; G Alexandre; A Lockhart; P Duroux
Journal:  Am Rev Respir Dis       Date:  1981-02

5.  Nomenclature for leukotrienes.

Authors:  B Samuelsson; S Hammarström
Journal:  Prostaglandins       Date:  1980-05

6.  Physiological disposition of verapamil in man.

Authors:  M Schomerus; B Spiegelhalder; B Stieren; M Eichelbaum
Journal:  Cardiovasc Res       Date:  1976-09       Impact factor: 10.787

7.  The role of calcium in the generation of intracellular SRS-A in passively sensitized human lung challenged with antigen.

Authors:  B J Hutchcroft; R P Orange
Journal:  Clin Allergy       Date:  1980-09

8.  The effect of verapamil on histamine and methacholine-induced bronchoconstriction.

Authors:  K R Patel
Journal:  Clin Allergy       Date:  1981-09

9.  Calcium antagonists in exercise-induced asthma.

Authors:  K R Patel
Journal:  Br Med J (Clin Res Ed)       Date:  1981-03-21

10.  A calcium antagonist, nifedipine, modifies exercise-induced asthma.

Authors:  P J Barnes; N M Wilson; M J Brown
Journal:  Thorax       Date:  1981-10       Impact factor: 9.139
  10 in total
  8 in total

Review 1.  Calcium channel blockers and asthma.

Authors:  S Y So; M Ip; W K Lam
Journal:  Lung       Date:  1986       Impact factor: 2.584

Review 2.  Heterogeneity of calcium channels in mast cells and basophils and the possible relevance to pathophysiology of lung diseases: a review.

Authors:  N Chand; J L Perhach; W Diamantis; R D Sofia
Journal:  Agents Actions       Date:  1986-03

Review 3.  Clinical studies with calcium antagonists in asthma.

Authors:  P J Barnes
Journal:  Br J Clin Pharmacol       Date:  1985       Impact factor: 4.335

4.  Inhibition of histamine release from dispersed human lung and tonsillar mast cells by nicardipine and nifedipine.

Authors:  Y Y Kim; S T Holgate; M K Church
Journal:  Br J Clin Pharmacol       Date:  1985-05       Impact factor: 4.335

5.  Calcium-channel blockers and asthma.

Authors:  P J Barnes
Journal:  Thorax       Date:  1983-07       Impact factor: 9.139

6.  Inhibition of phospholipase A2 (PLA2) activity by nifedipine and nisoldipine is independent of their calcium-channel-blocking activity.

Authors:  J Chang; E Blazek; R P Carlson
Journal:  Inflammation       Date:  1987-09       Impact factor: 4.092

7.  Inhibition of allergic and non-allergic histamine secretion from rat peritoneal mast cells by calcium antagonists.

Authors:  N Chand; W Diamantis; J Pillar; R D Sofia
Journal:  Br J Pharmacol       Date:  1984-12       Impact factor: 8.739

8.  Relative activities of three calcium channel antagonists on histamine, acetylcholine and antigen-induced contractions of guinea pig ileum.

Authors:  A J Ingenito
Journal:  Agents Actions       Date:  1985-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.